AKT1 and neoplasm: In the light of the above mentioned literature data, it can be suggest that, also in laryngeal cancer, the intracrine effect of nuclear PTHrP can play a role in the tumor progression and development of resistance to cetuximab-combined treatment, through the activation of the PI3K/Akt pathway.